X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Orchid Chemicals with TTK HEALTHCARE - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ORCHID PHARMA LTD vs TTK HEALTHCARE - Comparison Results

ORCHID PHARMA LTD    Change

Orchid Chemicals & Pharmaceuticals Ltd. (Orchid) is today a globally recognized, integrated pharmaceutical company with core competencies in the development and manufacture of Active Pharmaceutical Ingredients (APIs) and Finished Dosage Forms as well... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ORCHID PHARMA LTD TTK HEALTHCARE ORCHID PHARMA LTD/
TTK HEALTHCARE
 
P/E (TTM) x -0.5 50.2 - View Chart
P/BV x 0.4 9.2 4.0% View Chart
Dividend Yield % 0.0 0.3 -  

Financials

 ORCHID PHARMA LTD   TTK HEALTHCARE
EQUITY SHARE DATA
    ORCHID PHARMA LTD
Sep-13
TTK HEALTHCARE
Mar-14
ORCHID PHARMA LTD/
TTK HEALTHCARE
5-Yr Chart
Click to enlarge
High Rs194663 29.2%   
Low Rs35399 8.8%   
Sales per share (Unadj.) Rs276.5535.6 51.6%  
Earnings per share (Unadj.) Rs-79.215.9 -496.7%  
Cash flow per share (Unadj.) Rs-43.520.0 -217.0%  
Dividends per share (Unadj.) Rs04.00 0.0%  
Dividend yield (eoy) %00.8 0.0%  
Book value per share (Unadj.) Rs53.9137.6 39.2%  
Shares outstanding (eoy) m70.457.77 906.7%   
Bonus/Rights/Conversions ESOP--  
Price / Sales ratio x0.41.0 41.8%   
Avg P/E ratio x-1.433.3 -4.3%  
P/CF ratio (eoy) x-2.626.5 -9.9%  
Price / Book Value ratio x2.13.9 55.0%  
Dividend payout %025.1 0.0%   
Avg Mkt Cap Rs m8,0674,127 195.4%   
No. of employees `0002.81.7 163.9%   
Total wages/salary Rs m2,527607 416.6%   
Avg. sales/employee Rs Th6,956.12,436.7 285.5%   
Avg. wages/employee Rs Th902.5355.2 254.1%   
Avg. net profit/employee Rs Th-1,993.072.5 -2,747.4%   
INCOME DATA
Net Sales Rs m19,4774,162 468.0%  
Other income Rs m40761 665.4%   
Total revenues Rs m19,8844,223 470.9%   
Gross profit Rs m1,103197 559.4%  
Depreciation Rs m2,51932 7,947.0%   
Interest Rs m5,22730 17,480.9%   
Profit before tax Rs m-6,236197 -3,170.4%   
Minority Interest Rs m200-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m5110-   
Tax Rs m-12573 -172.0%   
Profit after tax Rs m-5,580124 -4,503.9%  
Gross profit margin %5.74.7 119.5%  
Effective tax rate %2.037.0 5.4%   
Net profit margin %-28.73.0 -962.4%  
BALANCE SHEET DATA
Current assets Rs m11,0141,629 676.3%   
Current liabilities Rs m32,0601,058 3,030.8%   
Net working cap to sales %-108.113.7 -787.7%  
Current ratio x0.31.5 22.3%  
Inventory Days Days9530 318.6%  
Debtors Days Days3434 99.9%  
Net fixed assets Rs m29,440556 5,292.1%   
Share capital Rs m70578 906.7%   
"Free" reserves Rs m2,043878 232.6%   
Net worth Rs m3,8001,069 355.4%   
Long term debt Rs m9,018159 5,682.4%   
Total assets Rs m46,5102,399 1,938.4%  
Interest coverage x-0.27.6 -2.5%   
Debt to equity ratio x2.40.1 1,599.0%  
Sales to assets ratio x0.41.7 24.1%   
Return on assets %-0.86.4 -11.9%  
Return on equity %-146.911.6 -1,267.4%  
Return on capital %-3.718.5 -20.2%  
Exports to sales %37.90.8 4,791.6%   
Imports to sales %22.61.4 1,614.9%   
Exports (fob) Rs m7,37833 22,424.3%   
Imports (cif) Rs m4,40658 7,557.6%   
Fx inflow Rs m7,51333 22,836.8%   
Fx outflow Rs m5,64963 8,939.4%   
Net fx Rs m1,865-30 -6,155.5%   
CASH FLOW
From Operations Rs m1,682127 1,328.4%  
From Investments Rs m-9,860-146 6,753.7%  
From Financial Activity Rs m6,64422 30,337.0%  
Net Cashflow Rs m-1,5353 -61,400.0%  

Share Holding

Indian Promoters % 32.3 65.4 49.4%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 4.6 3.7 124.3%  
FIIs % 3.3 5.2 63.5%  
ADR/GDR % 4.6 0.0 -  
Free float % 55.3 25.8 214.3%  
Shareholders   84,811 12,723 666.6%  
Pledged promoter(s) holding % 54.9 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ORCHID PHARMA LTD With:   GLENMARK PHARMA  UNICHEM LAB  WYETH LTD  DIVIS LABORATORIES  FULFORD INDIA  

Compare ORCHID PHARMA LTD With:   ACTAVIS (US)  MYLAN (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Weak Start to the Week; PSU & Metal Stocks Fall(Closing)

Indian share markets continued to witness selling pressure in the afternoon session as benchmark Sensex slipped below the 34,000-mark.

Related Views on News

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

Here's What You Should Do in this Market Crash(The 5 Minute Wrapup)

Feb 6, 2018

The market correction has provided a golden opportunity to buy five high-quality safe stocks.

The Era of Easy Money is Coming to an End. What Happens Now?(Vivek Kaul's Diary)

Feb 9, 2018

The easy money policy of the Federal Reserve of the United States, which drove up stock markets all over the world, is ending, with the Federal Reserve looking to shrink its balance sheet.

The Markets Want Your Money. Don't Give It to Them.(Smart Contrarian)

Feb 9, 2018

MFs are having a gala time taking money from over-eager investors and funneling it into equities. Smart investors, though, know better than to do that.

The Big Gamble(The Honest Truth)

Feb 15, 2018

Once you accept the fact that elections are round the corner and that this budget is geared to reach a 40% target, everything makes sense.

When Small is Not Always Beautiful(Chart Of The Day)

Feb 6, 2018

Big companies enjoying tax deductions and exemptions have an edge over the small companies.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

ORCHID PHARMA LTD SHARE PRICE


Feb 19, 2018 03:37 PM

TRACK ORCHID PHARMA LTD

  • Track your investment in ORCHID PHARMA LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ORCHID PHARMA LTD

ORCHID PHARMA LTD 8-QTR ANALYSIS

COMPARE ORCHID PHARMA LTD WITH

MARKET STATS